Sanford Advisory Services’s AbbVie ABBV Stock Holding History

Sanford Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$535K	Sell	3,312 -47	-1%	-$7.21K	0.13%	82
2022 Q3	$450K	Sell	3,359 -396	-11%	-$56.8K	0.13%	70
2022 Q2	$575K	Buy	3,755 +657	+21%	+$100K	0.16%	57
2022 Q1	$502K	Buy	3,098 +153	+5%	+$22.2K	0.14%	63
2021 Q4	$399K	Buy	2,945 +4	+0.1%	+$473	0.09%	77
2021 Q3	$317K	Buy	2,941 +4	+0.1%	+$457	0.08%	84
2021 Q2	$331K	Buy	2,937 +3	+0.1%	+$338	0.09%	81
2021 Q1	$318K	Buy	2,934 +4	+0.1%	+$428	0.09%	81
2020 Q4	$313K	Buy	+2,930	New	+$282K	0.1%	72

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sanford Advisory Services's ABBV Position: Q4 2022 in Review

Sanford Advisory Services reduced its AbbVie (ABBV) stake by 1.4% in Q4 2022, selling an estimated $7.21K and leaving 3,312 shares worth $535K. The position accounts for 0.13% of the portfolio, ranked #82.

Sanford Advisory Services first reported a position in ABBV in Q4 2020 and has held it in 9 quarters since. The position peaked at $575K in Q2 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Sanford Advisory Services held 3,312 shares of AbbVie worth $535K as of Q4 2022.
Sanford Advisory Services sold 47 AbbVie shares in Q4 2022, an estimated $7.21K.
AbbVie made up 0.13% of Sanford Advisory Services's portfolio in Q4 2022, its #82 holding.
Sanford Advisory Services first reported a position in AbbVie in Q4 2020 and has held it in 9 quarters since.
Sanford Advisory Services's AbbVie position peaked at $575K in Q2 2022.
3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Sanford Advisory Services's 13F filing for Q4 2022, filed 8 Feb 2023.